Compound ID | 2771
Class: Natural product antibiotic
Details of activity: | Active against Mycobacterium tuberculosis; interferes with glucose utilization; competes as a substrate in adenosine anabolism |
Description: | Natural product from Streptomyces tubercidicus; also shows anti-tumour activity; shows host toxicity in preclinical studies |
Institute where first reported: | Scientific Research Institute, Tokyo |
Year first mentioned: | 1957 |
Highest developmental phase: | Preclinical |
Development status: | Experimental |
Chemical structure(s): | |||||||||||
|
|